View Post

Using Evidence for Decision-Making in Health Benefits Package Design: iDSI co-hosts major event, bringing together policy-makers from six North Eastern Indian States

By Laura Downey Feb. 27, 2019

As India moves towards the achievement of Universal Health Coverage (UHC), finding robust and evidence-based answers to the challenges of defining which services should be publicly funded, for whom and how, becomes increasingly important. The introduction of ‘Modicare’, the nascent health insurance scheme announced out by the Indian Federal Government to cover some 500 million citizens, brings with it a …

FCO People to People Dialogue and the Prosperity Fund

By Kalipso Chalkidou Dec. 6, 2016

On 5 Dec, Kalipso Chalkidou, Director of the Global Health and Development Group (GHD), represented Imperial group at the 4th People to People dialogue in Beijing, convened by Vice Minister Cui Li from the National Health and Family Planning Commission (NHFPC) of China, and the UK’s Secretary of State for Health Jeremy Hunt. Healthy ageing, improving quality of care and …

GHD sent representatives to the Healthcare Quality Forum in Mexico City, October 26-28, 2016

Nov. 7, 2016

The Global Health and Development Group at Imperial College, London (GHD, formerly NICE International) sent representatives to the “National and International Healthcare Quality Forum / Second Latin American Forum on Healthcare Quality and Safety” held in Mexico City, October 26-28, 2016. Francis Ruiz of GHD, along with Professor Stephen Campbell of the University of Manchester, and Professor Daniel Keenan (Chair, …

Combination of Policy Process and Technical Evidence: Setting Priority on Health Screening in Thailand

By Yot Teerawattananon , Karlena Luz Jan. 25, 2016

  More and more, private health care is promoting health checkups. The more tests the consumer takes the higher the costs are incurred. Nevertheless, expensive tests cannot guarantee better health outcomes. Evidence even suggests that some tests such as prosthetic-specific antigen tests have definite harms that outweigh the benefits due to over diagnosis and over treatment. Meanwhile, some countries allocate …

Towards an evidence-based National Action Plan on Antimicrobial Resistance in Vietnam

By Françoise Cluzeau , Ashok Manandhar Nov. 25, 2015

Since August 2015, NICE International, an iDSI core partner, has been involved in a two-year collaboration to develop the existing National Action Plan on Antimicrobial Resistance (AMR) in Vietnam, funded by the Newton Fund. This project brings together the Vietnamese Ministry of Health, National Hospital for Tropical Diseases, and the Health Strategy and Policy Institute (HSPI) with the Oxford University …